Kadar Pemulihan Faktor VIII pada Pembuatan Kriopresipitat

45

DAFTAR PUSTAKA

Allain JP. Non-factor VIII related constituents in concentrates. Scand J
Haematol. 1984;33(suppl 41):173-180
Bucur SZ, Hillyer CD (2001). Cryoprecipitate and Related Products. In:
Hillyer CD, Hillyer KL, Strobl FJ, Jefferies LC, Silberstein LE.
Handbook of Transfusion Medicine. 6 47-51
Contreras, M (1995). Penerjemah Oswari, J., Petunjuk Penting Transfusi, Ed.
2, Jakarta EGC.
Djajadiman G. Penanggulangan anemia pasca pendarahan. Bagian Ilmu
Kesehatan Anak FKUI/RSCM Jakarta.
Galel SA, Malone JM, Viele MK (2004). Transfusion Medicine. In: Green JP,
Foerster

J,

Lukens

JN,et


al

editor.

Wintrobe’s

Clinical

Haematology.ed 11. Philadelphia : Lippincott Williams & Wilkins, 24
855-856
Hillyer CD,et al, (2007). Blood Banking And Transfusion Medicine: Basic
Priniciples And Practice 2nd ed. Elsevier. Philladelphia. 12 197
Hambley H, Davidson JF, Walker ID, Small M, Prentice CRM (1983).
Freeze dried cryoprecipitate: a clinical evaluation. J Clin Pathol36
574-576
New York State Council on Human Blood and Transfusion Services
(2011). Guidelines For The Administration of Cryoprecipitate. 4th
ed.


46

Klein HG, Anstee JD (2005).The transfusion of platelets, leucocytes,
haematopoietic cells and plasma components. In : Mollison’s Blood
Transfusion

in

Clinical

Medicine,11th

edition.

Blackwell

Publishing.USA. 14 636-637
Kasper CK, Myhre BA, McDonald JD, et al (1975). Determinant of Factor
VIII Recovery in Cryoprecipitate.Transfusion. 15 (4) 312-322
Lwanga SK, Lemeshow S. Sample Size Determination in Health Studies, A

Practical Manual. World Health Organization. Geneva
PT Setia Anugrah Medika. Petunjuk Penggunaan CoaDATA 4004.
Rosén S, Casoni CM, Factor VIII,Chromogenic determination of factor VIII
activity in plasma and factor VIII concentrates. In: Factor VIII,
Chromogenix Monograph Series. Chromogenix -Instrumentation
Laboratory.Italia
Roberts HR, Escobar M, White GC (2006). Hemophilia A and hemophilia B.
In: Lichtman MA, Beutler E, Kipps TJ, et al. editor. Williams
Hematology. 7th ed. McGraw-Hill.Newyork. 115 1867-1875
Syafei, Tann G (1980). Blood components for developing countries. The
Lancet,Volume 316, Issue 8202, Page 1036, (Letter to Edition) 8
November.
Sweeney JD (1999), Rizk Y. Plasma and cryoprecipitate : indications and
dosing. In :Vademecum, Clinical Transfusion Medicine. Landes
Bioscience. 29 121-125

47

Shaz BH, Hillyer CD. 2009. Cryoprecipitate. In : Hillyer CD, Shaz BH, Zimring
JC, Abshire TC. Editor.Transfusion Medicine and Hemostasis –

Clinical and Laboratory Aspects.31 175-178
Sacher RA, McPherson RA (2004). Tinjauan klinis hasil pemeriksaan
laboratorium. Alih bahasa Pendit BU, Wulandari D, Hartanto
H.editor, ed 11.Jakarta.EGC
Setiabudy R (2002). Diagnosis hemofilia secara laboratorik Bagian
PatologiKlinik FKUI-RSCM Jakarta. Dibacakan pada Simposium
Diagnosis dan Penatalaksanaan Hemofilia. FKUI Jakarta.
Slichterr

SJ,

Henderson

C,

Harker

LA

(1976).


Preparation

of

Cryoprecipitated Factor VIII Concentrates. Transfusion. 6 (6) 616626
Tambunan KL, Widjanarko A (1990). Kelainan hemostasis bawaan. Dalam:
Soeparman dkk (eds). Ilmu Penyakit Dalam Jilid II. Balai Penerbit
FKUI.Jakarta 452-9
Unit Transfusi Darah PMI Pusat (2007) . Pedoman Pelayanan Transfusii
Darah. Ed 3. Buku 4